Report Detail

Request for Sample of this report

Other Global Rare Kidney Diseases Treatment Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4517830
    • |
  • 06 March, 2023
    • |
  • Global
    • |
  • 102 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

According to our (Global Info Research) latest study, the global Rare Kidney Diseases Treatment market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Rare Kidney Diseases Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Drug Class and by Distribution Channel. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Rare Kidney Diseases Treatment market size and forecasts, in consumption value ($ Million), 2018-2029
Global Rare Kidney Diseases Treatment market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Rare Kidney Diseases Treatment market size and forecasts, by Drug Class and by Distribution Channel, in consumption value ($ Million), 2018-2029
Global Rare Kidney Diseases Treatment market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Rare Kidney Diseases Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Rare Kidney Diseases Treatment market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Calliditas Therapeutics AB, GSK plc, Aurinia Pharmaceuticals, Inc., Amicus Therapeutics, Inc. and Shire (Takeda Pharmaceutical Company Limited), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Rare Kidney Diseases Treatment market is split by Drug Class and by Distribution Channel. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Drug Class and by Distribution Channel. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Drug Class
Enzyme Replacement Therapy
Monoclonal Antibodies
Others
Market segment by Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Sales
Market segment by players, this report covers
Calliditas Therapeutics AB
GSK plc
Aurinia Pharmaceuticals, Inc.
Amicus Therapeutics, Inc.
Shire (Takeda Pharmaceutical Company Limited)
Sanofi
Advicenne
Alexion Pharmaceuticals, Inc.
Horizon Therapeutics plc
Otsuka Pharmaceutical Co., Ltd.
Reata Pharmaceuticals, Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Rare Kidney Diseases Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Rare Kidney Diseases Treatment, with revenue, gross margin and global market share of Rare Kidney Diseases Treatment from 2018 to 2023.
Chapter 3, the Rare Kidney Diseases Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Drug Class and application, with consumption value and growth rate by Drug Class, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Rare Kidney Diseases Treatment market forecast, by regions, drug class and distribution channel, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Rare Kidney Diseases Treatment.
Chapter 13, to describe Rare Kidney Diseases Treatment research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Rare Kidney Diseases Treatment
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Rare Kidney Diseases Treatment by Drug Class
    • 1.3.1 Overview: Global Rare Kidney Diseases Treatment Market Size by Drug Class: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Rare Kidney Diseases Treatment Consumption Value Market Share by Drug Class in 2022
    • 1.3.3 Enzyme Replacement Therapy
    • 1.3.4 Monoclonal Antibodies
    • 1.3.5 Others
  • 1.4 Global Rare Kidney Diseases Treatment Market by Distribution Channel
    • 1.4.1 Overview: Global Rare Kidney Diseases Treatment Market Size by Distribution Channel: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospital Pharmacies
    • 1.4.3 Retail Pharmacies
    • 1.4.4 Online Sales
  • 1.5 Global Rare Kidney Diseases Treatment Market Size & Forecast
  • 1.6 Global Rare Kidney Diseases Treatment Market Size and Forecast by Region
    • 1.6.1 Global Rare Kidney Diseases Treatment Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Rare Kidney Diseases Treatment Market Size by Region, (2018-2029)
    • 1.6.3 North America Rare Kidney Diseases Treatment Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Rare Kidney Diseases Treatment Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Rare Kidney Diseases Treatment Market Size and Prospect (2018-2029)
    • 1.6.6 South America Rare Kidney Diseases Treatment Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Rare Kidney Diseases Treatment Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Calliditas Therapeutics AB
    • 2.1.1 Calliditas Therapeutics AB Details
    • 2.1.2 Calliditas Therapeutics AB Major Business
    • 2.1.3 Calliditas Therapeutics AB Rare Kidney Diseases Treatment Product and Solutions
    • 2.1.4 Calliditas Therapeutics AB Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Calliditas Therapeutics AB Recent Developments and Future Plans
  • 2.2 GSK plc
    • 2.2.1 GSK plc Details
    • 2.2.2 GSK plc Major Business
    • 2.2.3 GSK plc Rare Kidney Diseases Treatment Product and Solutions
    • 2.2.4 GSK plc Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 GSK plc Recent Developments and Future Plans
  • 2.3 Aurinia Pharmaceuticals, Inc.
    • 2.3.1 Aurinia Pharmaceuticals, Inc. Details
    • 2.3.2 Aurinia Pharmaceuticals, Inc. Major Business
    • 2.3.3 Aurinia Pharmaceuticals, Inc. Rare Kidney Diseases Treatment Product and Solutions
    • 2.3.4 Aurinia Pharmaceuticals, Inc. Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Aurinia Pharmaceuticals, Inc. Recent Developments and Future Plans
  • 2.4 Amicus Therapeutics, Inc.
    • 2.4.1 Amicus Therapeutics, Inc. Details
    • 2.4.2 Amicus Therapeutics, Inc. Major Business
    • 2.4.3 Amicus Therapeutics, Inc. Rare Kidney Diseases Treatment Product and Solutions
    • 2.4.4 Amicus Therapeutics, Inc. Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Amicus Therapeutics, Inc. Recent Developments and Future Plans
  • 2.5 Shire (Takeda Pharmaceutical Company Limited)
    • 2.5.1 Shire (Takeda Pharmaceutical Company Limited) Details
    • 2.5.2 Shire (Takeda Pharmaceutical Company Limited) Major Business
    • 2.5.3 Shire (Takeda Pharmaceutical Company Limited) Rare Kidney Diseases Treatment Product and Solutions
    • 2.5.4 Shire (Takeda Pharmaceutical Company Limited) Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Shire (Takeda Pharmaceutical Company Limited) Recent Developments and Future Plans
  • 2.6 Sanofi
    • 2.6.1 Sanofi Details
    • 2.6.2 Sanofi Major Business
    • 2.6.3 Sanofi Rare Kidney Diseases Treatment Product and Solutions
    • 2.6.4 Sanofi Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Sanofi Recent Developments and Future Plans
  • 2.7 Advicenne
    • 2.7.1 Advicenne Details
    • 2.7.2 Advicenne Major Business
    • 2.7.3 Advicenne Rare Kidney Diseases Treatment Product and Solutions
    • 2.7.4 Advicenne Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Advicenne Recent Developments and Future Plans
  • 2.8 Alexion Pharmaceuticals, Inc.
    • 2.8.1 Alexion Pharmaceuticals, Inc. Details
    • 2.8.2 Alexion Pharmaceuticals, Inc. Major Business
    • 2.8.3 Alexion Pharmaceuticals, Inc. Rare Kidney Diseases Treatment Product and Solutions
    • 2.8.4 Alexion Pharmaceuticals, Inc. Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Alexion Pharmaceuticals, Inc. Recent Developments and Future Plans
  • 2.9 Horizon Therapeutics plc
    • 2.9.1 Horizon Therapeutics plc Details
    • 2.9.2 Horizon Therapeutics plc Major Business
    • 2.9.3 Horizon Therapeutics plc Rare Kidney Diseases Treatment Product and Solutions
    • 2.9.4 Horizon Therapeutics plc Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Horizon Therapeutics plc Recent Developments and Future Plans
  • 2.10 Otsuka Pharmaceutical Co., Ltd.
    • 2.10.1 Otsuka Pharmaceutical Co., Ltd. Details
    • 2.10.2 Otsuka Pharmaceutical Co., Ltd. Major Business
    • 2.10.3 Otsuka Pharmaceutical Co., Ltd. Rare Kidney Diseases Treatment Product and Solutions
    • 2.10.4 Otsuka Pharmaceutical Co., Ltd. Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Otsuka Pharmaceutical Co., Ltd. Recent Developments and Future Plans
  • 2.11 Reata Pharmaceuticals, Inc.
    • 2.11.1 Reata Pharmaceuticals, Inc. Details
    • 2.11.2 Reata Pharmaceuticals, Inc. Major Business
    • 2.11.3 Reata Pharmaceuticals, Inc. Rare Kidney Diseases Treatment Product and Solutions
    • 2.11.4 Reata Pharmaceuticals, Inc. Rare Kidney Diseases Treatment Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Reata Pharmaceuticals, Inc. Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Rare Kidney Diseases Treatment Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Rare Kidney Diseases Treatment by Company Revenue
    • 3.2.2 Top 3 Rare Kidney Diseases Treatment Players Market Share in 2022
    • 3.2.3 Top 6 Rare Kidney Diseases Treatment Players Market Share in 2022
  • 3.3 Rare Kidney Diseases Treatment Market: Overall Company Footprint Analysis
    • 3.3.1 Rare Kidney Diseases Treatment Market: Region Footprint
    • 3.3.2 Rare Kidney Diseases Treatment Market: Company Product Type Footprint
    • 3.3.3 Rare Kidney Diseases Treatment Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Drug Class

  • 4.1 Global Rare Kidney Diseases Treatment Consumption Value and Market Share by Drug Class (2018-2023)
  • 4.2 Global Rare Kidney Diseases Treatment Market Forecast by Drug Class (2024-2029)

5 Market Size Segment by Distribution Channel

  • 5.1 Global Rare Kidney Diseases Treatment Consumption Value Market Share by Distribution Channel (2018-2023)
  • 5.2 Global Rare Kidney Diseases Treatment Market Forecast by Distribution Channel (2024-2029)

6 North America

  • 6.1 North America Rare Kidney Diseases Treatment Consumption Value by Drug Class (2018-2029)
  • 6.2 North America Rare Kidney Diseases Treatment Consumption Value by Distribution Channel (2018-2029)
  • 6.3 North America Rare Kidney Diseases Treatment Market Size by Country
    • 6.3.1 North America Rare Kidney Diseases Treatment Consumption Value by Country (2018-2029)
    • 6.3.2 United States Rare Kidney Diseases Treatment Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Rare Kidney Diseases Treatment Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Rare Kidney Diseases Treatment Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Rare Kidney Diseases Treatment Consumption Value by Drug Class (2018-2029)
  • 7.2 Europe Rare Kidney Diseases Treatment Consumption Value by Distribution Channel (2018-2029)
  • 7.3 Europe Rare Kidney Diseases Treatment Market Size by Country
    • 7.3.1 Europe Rare Kidney Diseases Treatment Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Rare Kidney Diseases Treatment Market Size and Forecast (2018-2029)
    • 7.3.3 France Rare Kidney Diseases Treatment Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Rare Kidney Diseases Treatment Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Rare Kidney Diseases Treatment Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Rare Kidney Diseases Treatment Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Rare Kidney Diseases Treatment Consumption Value by Drug Class (2018-2029)
  • 8.2 Asia-Pacific Rare Kidney Diseases Treatment Consumption Value by Distribution Channel (2018-2029)
  • 8.3 Asia-Pacific Rare Kidney Diseases Treatment Market Size by Region
    • 8.3.1 Asia-Pacific Rare Kidney Diseases Treatment Consumption Value by Region (2018-2029)
    • 8.3.2 China Rare Kidney Diseases Treatment Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Rare Kidney Diseases Treatment Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Rare Kidney Diseases Treatment Market Size and Forecast (2018-2029)
    • 8.3.5 India Rare Kidney Diseases Treatment Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Rare Kidney Diseases Treatment Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Rare Kidney Diseases Treatment Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Rare Kidney Diseases Treatment Consumption Value by Drug Class (2018-2029)
  • 9.2 South America Rare Kidney Diseases Treatment Consumption Value by Distribution Channel (2018-2029)
  • 9.3 South America Rare Kidney Diseases Treatment Market Size by Country
    • 9.3.1 South America Rare Kidney Diseases Treatment Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Rare Kidney Diseases Treatment Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Rare Kidney Diseases Treatment Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Rare Kidney Diseases Treatment Consumption Value by Drug Class (2018-2029)
  • 10.2 Middle East & Africa Rare Kidney Diseases Treatment Consumption Value by Distribution Channel (2018-2029)
  • 10.3 Middle East & Africa Rare Kidney Diseases Treatment Market Size by Country
    • 10.3.1 Middle East & Africa Rare Kidney Diseases Treatment Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Rare Kidney Diseases Treatment Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Rare Kidney Diseases Treatment Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Rare Kidney Diseases Treatment Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Rare Kidney Diseases Treatment Market Drivers
  • 11.2 Rare Kidney Diseases Treatment Market Restraints
  • 11.3 Rare Kidney Diseases Treatment Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Rare Kidney Diseases Treatment Industry Chain
  • 12.2 Rare Kidney Diseases Treatment Upstream Analysis
  • 12.3 Rare Kidney Diseases Treatment Midstream Analysis
  • 12.4 Rare Kidney Diseases Treatment Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Rare Kidney Diseases Treatment. Industry analysis & Market Report on Rare Kidney Diseases Treatment is a syndicated market report, published as Global Rare Kidney Diseases Treatment Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Rare Kidney Diseases Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,773.56
    		4,160.34
    		5,547.12
    		3,246.84
    		4,870.26
    		6,493.68
    		543,784.80
    		815,677.20
    		1,087,569.60
    		290,475.60
    		435,713.40
    		580,951.20
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo